Company Announcements Xavo and BSSN Software announced in September a collaboration integrating their respective Seahorse Scientific Workbench and Xavo Lab Logistics to review analytical and biological screening results. In September, DNASTAR appointed Pure Health Medical Supplies as a distributor for the Middle East. BioDiscovery and lab services firm AKESOgen announced a comarketing partnership. In October, […]
Company Announcements Horizon Discovery in October signed an in-licensing and option agreement with Servier for novel kinase inhibitors. Horizon will use its platform to identify the populations of cancer patients most likely to respond to the in-licensed compounds. BIOKÉ signed an exclusive agreement to distribute Horizon Discovery’s HDx Reference Standards in the Netherlands. For the […]
With a slight uptick in inflation, improved manufacturing and strong employment reported in November, the US Federal Reserve has now targeted the beginning of December for a potential rate hike. In addition, US third quarter GDP growth was revised upwards 60 basis points to 2.1% due to increased inventory buildup. However, the stronger inventories may […]
Company Announcements WuXi NextCODE announced in October a long-term partnership with Sidra Medical and Research Center, the genomics and informatics hub for the Qatar Genome Project, to provide and codevelop research and bioinformatics programs. DNAnexus integrated its DNAnexus cloud genomics software with QIAGEN’s Ingenuity Variant Analysis platform. South Korea–based Celemics, a provider of target enrichment […]
China, the second largest drug market, has increased its commitment to its domestic pharmaceutical industry. This year, sales of the country’s 10 largest pharmaceutical companies grew an average of 12%, according to IMS Consulting. Multinational drug firms, including Novo Nordisk and GlaxoSmithKline, report increased competition. Domestic firms, such as Gan & Lee Pharmaceuticals and Fosun […]
The latest UK spending review includes increased funding for science, providing an additional £500 million ($769 million) per year by 2020 for the £4.7 billion science budget in order to account for inflation. In addition, the science infrastructure budget will increase 10% to £1.2 billion per year by 2021 and includes £150 million for a […]
R&D spending by the top 25 Indian pharmaceutical companies rose 28.8% to INR 9,250 crore ($1.4 billion) for the year ending March 2015. Sales as a percentage of revenues rose from 6.6% to 7.0%. The top three R&D spenders were Sun Pharmaceutical Industries, whose expenditures rose 87.0% to INR 1,856 crore; Dr. Reddy’s Laboratories, whose […]
New public and private funding commitments were announced for clean energy R&D at this month’s UN climate summit. As part of the new Mission Innovation initiative, 20 countries, including China, Saudi Arabia and the US, plan to double their current combined $10 billion in spending on clean energy R&D within five years. The US accounts […]
This month, the FDA finalized three new rules that are part of the Food Safety Modernization Act. The Produce Safety rule includes requirements for agricultural water testing, use of biological soil amendments, and prevention of sprout contamination. The Foreign Supplier Verification Program rule requires importers to verify that their suppliers meet US safety standards. Exempted […]
By 2020, spending on medicines will total $1.4 trillion, a 29%–32% increase in constant dollars from 2015, but down from 35% growth over the previous five-year period. The volume of medicines used from 2015 to 2020 will increase 24%. Original brands, nonoriginal brands, unbranded and OTC medicines will account for 52%, 21%, 14% and 13% […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
